FULL PROFESSOR

e-mail:  palombi@uniroma2.it
Telefono: +39 06 7259 6614
SSD: MED/42
SC: 06/M1
Macro-area:
Igiene generale e applicata, scienze infermieristiche e statistica medica
Campi di interesse: 
- HIV Epidemiology, PMTCT, drug resistance
- Elderly
- Public Health

 Prof. Leonardo Palombi - DIRECTOR of the DEPARTMENT of BIOMEDICINE AND PREVENTION

---

CURRICULUM VITAE

Dr. Leonardo Palombi, MD is a full Professor of Hygiene, Epidemiology and Public Health at University Tor Vergata, Faculty of Medicine.  He is also scientific director of the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) Program, a large private/public intervention in 10 African countries with 33 health centers and 20 molecular labs, run by a faith-based organization: the Community of Sant’Egidio.  He is the coordinator of a PhD on Nursing sciences and Public Health at University of Torvergata, Rome.
His main area of research has been HIV infection, infectious/ tropical diseases, global health, health planning and epidemiology of ageing. He has been Co-Principal Investigator in a number of national studies and international interventions. He has been involved as Managing Director for two World Bank Interventions in the Balcan area (1998-2000) and in Mozambique (2004-2007). He was a member of the National Italian Committee for HIV/AIDS (2003-2005) and was involved in the WHO guidelines preparation in Geneva for HIV (PMTCT 2006 -2008, HIVRESnet 2009, Consolidated Guidelines, 2012).
Leonardo Palombi authored more than 250 publications (H Index 22), books and oral presentations at international meetings.

Link: https://www.researchgate.net/profile/Leonardo_Palombi

Selected papers

• Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV ; Palombi L. et all, AIDS, 2007
• Predicting stroke inpatient rehabilitation outcome: The prominent role of neuropsychological disorders ; Paolucci, S., Antonucd, G., Gialloreti, L.E., (...), Protest, L., Palombi, L.  ; European Neurology, 2007
• Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings; Marazzi, M.C., Liotta, G., Germano, P., (...), Nielsen-Saines, K., Palombi, L.  ; AIDS Research and Human Retroviruses, 2008
• Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral-treated patients in sub-Saharan African sites with comprehensive monitoring availability  ; Palombi, L., Marazzi, M.C., Guidotti, G., (...), San Lio, M.M., De Luca, A. h;  Clinical Infectious Diseases, 2009
• Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding . Marazzi, M.C., Nielsen-Saines, K., Buonomo, E., (...), Ceffa, S., Palombi, L.  ; Pediatric Infectious Disease Journal, 2009.
• Nevirapine-induced hepatotoxicity and pharmacogenetics: A retrospective study in a population from Mozambique . Ciccacci, C., Borgiani, P., Ceffa, S., (...), Novelli, G., Palombi, L.  ; Pharmacogenomics, 2010